Filters:
Investigator: Anne Longo1 Projects | 1 Researchers | $5,609,700 Invested
2024
PharmatrophiX
Anne Longo, BA
Phase 2b/3 trial of LM11A-31-BHS for Alzheimer's Disease
Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Anne Longo, BA
Phase 2b/3 trial of LM11A-31-BHS for Alzheimer's Disease